Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
M.D. Anderson Cancer Center
Mayo Clinic
Transgene
Bolt Biotherapeutics, Inc.
Tempus AI
Actym Therapeutics, Inc.
Young Adult Survivors United
MacroGenics
Numab Therapeutics AG
NuCana plc
University of Virginia
NRG Oncology
M.D. Anderson Cancer Center
Kymab Limited
Turnstone Biologics, Corp.
Seagen Inc.
Aminex Therapeutics, Inc.
Astellas Pharma Inc
National Cancer Institute (NCI)
Institut Cancerologie de l'Ouest
Novartis
Pfizer
Pfizer
ADC Therapeutics S.A.
Eisai Inc.
Atreca, Inc.
Fate Therapeutics
Hoffmann-La Roche
University of Pennsylvania
Oncorus, Inc.
Pfizer
Nektar Therapeutics
Rubius Therapeutics
Duke University
MacroGenics
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Seagen Inc.
Lumos Pharma
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
Yale University
National Institutes of Health Clinical Center (CC)
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Cota Inc.